These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34338433)

  • 1. An inducible Cldn11-CreER
    Ortsäter H; Hernández-Vásquez MN; Ulvmar MH; Gow A; Mäkinen T
    Genesis; 2021 Aug; 59(7-8):e23439. PubMed ID: 34338433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a tamoxifen-inducible Vsx1-CreER
    Baudouin C; Pelosi B; Courtoy GE; Achouri Y; Clotman F
    Genesis; 2021 Aug; 59(7-8):e23435. PubMed ID: 34080769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
    Martinez-Corral I; Stanczuk L; Frye M; Ulvmar MH; Diéguez-Hurtado R; Olmeda D; Makinen T; Ortega S
    Angiogenesis; 2016 Jul; 19(3):433-45. PubMed ID: 26993803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporally controlled somatic mutagenesis in smooth muscle.
    Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
    Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis.
    Zhang L; Zhang B; Han SJ; Shore AN; Rosen JM; Demayo FJ; Xin L
    Transgenic Res; 2012 Oct; 21(5):1117-23. PubMed ID: 22350718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-fidelity
    Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
    Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
    Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
    Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
    Xu J; Yao G; Ru Y; Xie S
    Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
    Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
    Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.
    Zhu M; Chen M; Lichtler AC; O'Keefe RJ; Chen D
    Osteoarthritis Cartilage; 2008 Jan; 16(1):129-30. PubMed ID: 17888690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
    Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
    Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDGFRβ-P2A-CreER
    Cuervo H; Pereira B; Nadeem T; Lin M; Lee F; Kitajewski J; Lin CS
    Angiogenesis; 2017 Nov; 20(4):655-662. PubMed ID: 28752390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified method to quantify valve back-leak uncovers severe mesenteric lymphatic valve dysfunction in mice deficient in connexins 43 and 37.
    Castorena-Gonzalez JA; Srinivasan RS; King PD; Simon AM; Davis MJ
    J Physiol; 2020 Jun; 598(12):2297-2310. PubMed ID: 32267537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Autosomal
    Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
    Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
    Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.
    Qiu HY; Guo C; Cheng XW; Huang Y; Xiong ZQ; Ding YQ
    Genesis; 2008 Jun; 46(6):324-8. PubMed ID: 18543300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of CD4CreER(T²) transgenic mice to study development of peripheral CD4-T-cells.
    Aghajani K; Keerthivasan S; Yu Y; Gounari F
    Genesis; 2012 Dec; 50(12):908-13. PubMed ID: 22887772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Nkx2-5/CreER transgenic mice for inducible Cre expression in developing hearts.
    Ranjbarvaziri S; Park S; Nguyen NB; Gilmore WB; Zhao P; Ardehali R
    Genesis; 2017 Aug; 55(8):. PubMed ID: 28589709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.